buthionine sulfoximine has been researched along with Local Neoplasm Recurrence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, CP; Bailey, HH; Groshen, S; Hasenauer, B; Maris, JM; Matthay, KK; Neglia, JP; Perentesis, JP; Reynolds, CP; Seeger, RC; Villablanca, JG | 1 |
Anderson, CP; Cho, H; Cohn, SL; Czarnecki, S; Goodarzian, F; Groshen, S; Hasenauer, CE; Kang, MH; Lai, H; Marachelian, A; Maris, JM; Matthay, KK; Reynolds, CP; Shimada, H; Tsao-Wei, D; Villablanca, JG; Volchenboum, SL | 1 |
Bookman, MA; Brennan, J; Comis, RL; Gallo, JM; Halbherr, T; Hamilton, TC; Hoffman, J; Kilpatrick, D; LaCreta, FP; O'Dwyer, PJ; Ozols, RF; Young, RC | 1 |
3 trial(s) available for buthionine sulfoximine and Local Neoplasm Recurrence
Article | Year |
---|---|
Pilot study of intravenous melphalan combined with continuous infusion L-S,R-buthionine sulfoximine for children with recurrent neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Child; Chromatography, High Pressure Liquid; Female; Glutathione; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects | 2015 |
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Child; Child, Preschool; Drug Synergism; Female; Glutamate-Cysteine Ligase; Glutathione; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Melphalan; Myeloablative Agonists; Neoplasm Recurrence, Local; Neuroblastoma | 2016 |
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Linear Models; Male; Melphalan; Methionine Sulfoximine; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Neutrophils; Radiography; Vomiting | 1996 |